false 0001607962 00-0000000 0001607962 2026-10-01 2026-10-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 1, 2026

 

Lifeward Ltd.

 

(Exact name of registrant as specified in its charter)

 

Israel   001-36612   Not applicable

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(IRS Employer

Identification No.) 

 

2 Cabot Rd., Hudson, MA   01749
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: +508.251.1154

 

Not Applicable

 

(Former name or former address, if changed since last report)

 

Securities registered pursuant to

Section 12(b) of the Exchange Act

  Trading Symbol  

Name of each exchange

on which registered

Ordinary Shares, no par value   LFWD   Nasdaq Capital Market

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

As previously disclosed in the Current Report on Form 8-K filed by Lifeward Ltd. (the “Company”) with the Securities and Exchange Commission on August 31, 2026, Almog Adar’s departure as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer became effective on September 30, 2026.

 

Effective October 1, 2026, the Company designated Josh Hexter, the Company’s Interim Chief Executive Officer and principal executive officer, to also serve as the Company’s interim principal financial officer and principal accounting officer. Mr. Hexter will serve in these capacities until November 1, 2026, when, as previously disclosed in the August 31, 2026 Form 8-K, Rami Aviram’s appointment as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer becomes effective.

 

Mr. Hexter will not receive any additional compensation in connection with this designation. The information concerning Mr. Hexter required by Item 5.02(c) of Form 8-K was included in the August 31, 2026 Form 8-K and is incorporated herein by reference.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Lifeward Ltd.
     
Dated: October 1, 2026 By: /s/ Josh Hexter
  Name: Josh Hexter
  Title: Interim Chief Executive Officer

 

 

 


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

XBRL SCHEMA FILE

XBRL LABEL FILE

XBRL PRESENTATION FILE

IDEA: R1.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: zk2636181_htm.xml